Uncovering the Power of Diabetes Technology: CGM and Its Metrics

1. Continuous glucose monitors (CGMs) allow patients to be more involved in their diabetes management by delivering actionable data and real-time feedback

a) True
b) False

2. Time in range (TIR) has a direct association with the risk of microvascular complications and can be used to assess glycemic control.

a) True
b) False

3. The average TIR goal is 70% for most people with diabetes, however, this should be adjusted to each individual.

a) True
b) False

4. CGMs rank highest among diabetes technology options in relation to:

a) Improving clinical outcomes
b) Positively influencing patient diet behavior
c) Increasing patient compliance
d) All of the above

5. Compression lows, which lead to false low readings, can occur when sleeping in certain positions. When lying on the sensor, this pressure reduces the volume of interstitial fluid from which blood glucose is measured. Less volume can translate to less glucose, then incorrect low readings and alerts.

a) True
b) False

6. The measurement of A1C can be impacted by:

a) Anemia
b) Thyroid disease
c) Organ transplantation
d) Living at a high altitude
e) All of the above

7. TIR provides a more timely and accurate assessment of glucose variation, allowing for more informed decisions to help individualize diabetes management.

a) True
b) False

8. The ambulatory glucose profile (AGP) can identify:

a) Glucose variability
b) Factors that affect glucose
c) Patterns of hypoglycemia
d) Patterns of hyperglycemia
e) All of the above

9. Some different ways to avoid or treat CGM burnout include changing perspectives from problems to possibilities, changing alarm sounds and ranges for highs and lows, or taking a technology break.

a) True
b) False